- idUS
- Listar por autor
Listar por autor "Dreno, Brigitte"
Mostrando ítems 1-3 de 3
-
Artículo
5-year outcomes with cobimetinib plus vemurafenib in BRAFV600 mutation⇓positive advanced melanoma: extended follow-up of the coBRIM study
Ascierto, Paolo Antonio; Dreno, Brigitte; Larkin, James; Ribas, Antoni; Cruz Merino, Luis de la; McArthur, Grant A. (American Association for Cancer Research, 2021)Purpose: The randomized phase III coBRIM study (NCT01689519) demonstrated improved progression-free survival (PFS) and ...
-
Artículo
Clinical features of serous retinopathy observed with cobimetinib in patients with BRAF‑mutated melanoma treated in the randomized coBRIM study
Cruz Merino, Luis de la; Di Guardo, Lorenza; Grob, Jean Jacques; Venosa, Alfredo; Larkin, James; McArthur, Grant A.; Dreno, Brigitte (Biomed Central LTD, 2017)Background: Serous chorioretinopathy has been associated with MEK inhibitors, including cobimetinib. We describe the ...
-
Artículo
Health-related quality of life impact of cobimetinib in combination with vemurafenib in patients with advanced or metastatic BRAFV600 mutation–positive melanoma
Dreno, Brigitte; Ascierto, Paolo A.; Atkinson, Victoria; Liszkay, Gabriella; Maio, Michele; Mandala, Mario; Cruz Merino, Luis de la; Ribas, Antoni (Nature publishing group, 2018)Background: In the coBRIM study, cobimetinib plus vemurafenib (C þ V) significantly improved survival outcomes vs placebo ...